Population Pharmacokinetics of Erlotinib in Patients With Non–small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients

2020 ◽  
Vol 42 (7) ◽  
pp. 1302-1316
Author(s):  
Evelina Cardoso ◽  
Monia Guidi ◽  
Nihel Khoudour ◽  
Pascaline Boudou-Rouquette ◽  
Elizabeth Fabre ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Population Pharmacokinetics ◽  
Cell Lung Cancer ◽  
Older Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Individualized Dosing ◽  
Dosing Regimens

The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer

Drugs & Aging ◽  
2018 ◽  
Vol 35 (9) ◽  
pp. 819-834 ◽  
Author(s):  
Fabio Gomes ◽  
Rebecca Tay ◽  
Jaseela Chiramel ◽  
Raffaele Califano
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Older Patients ◽  
Small Cell ◽  
Targeted Agents ◽  
Small Cell Lung

Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients

2020 ◽  
Vol 11 (7) ◽  
pp. 1145-1153
Author(s):  
Madison Grinnell ◽  
Adams Kusi Appiah ◽  
Michael Baine ◽  
Vinicius Ernani ◽  
Alissa Marr ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adjuvant Chemotherapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Older Patients ◽  
Early Stage ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Causal Effects of Time-Dependent Treatments in Older Patients with Non-Small Cell Lung Cancer

PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0121406
Author(s):  
Igor Akushevich ◽  
Konstantin Arbeev ◽  
Julia Kravchenko ◽  
Mark Berry
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Older Patients ◽  
Small Cell ◽  
Time Dependent ◽  
Causal Effects ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document